Activity value 72china Supplier,Last transaction date:
2026-04-30
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for suli pharmaceutical technologies jian from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 4 transactions, with a transaction quantity of 16.4 and a transaction weight of 0.
YearTransactionsQuantityWeight
202541.680
2026416.40
Bill of lading data
<
1/15
>
Trade date
2026/04/30
B/L No.
——
Suppliers
suli pharmaceutical technologies jian
Buyers
m/s. global pharmaceuticals pakistan
POLs
——
PODs
ipaf
Supply area
China
Purchas area
Pakistan
Weight
——
Amount
1.022604
Hs code
29335990
Product tags
tofacitinib citrate
Product description
TOFACITINIB CITRATE
Expand
Trade date
2026/04/30
B/L No.
——
Suppliers
suli pharmaceutical technologies jian
Buyers
m/s. global pharmaceuticals pakistan
POLs
——
PODs
ipaf
Supply area
China
Purchas area
Pakistan
Weight
——
Amount
1.022604
Hs code
29335990
Product tags
tofacitinib citrate
Product description
TOFACITINIB CITRATE
Expand
Trade date
2026/04/30
B/L No.
——
Suppliers
suli pharmaceutical technologies jian
Buyers
m/s. global pharmaceuticals pakistan
Hs code
29332900
Product tags
bat,chi,daclatasvir dihydrochloride,ipm,gin,pharmaceutical raw material,dalia,bran
Product description
PHARMACEUTICAL RAW MATERIAL..... .. DACLATASVIR DIHYDROCHLORIDE .... ........BATCH NO : DL089-20250501 .....MFG DATE : 29/05/2025.....EXP DATE : 28/05/2027 ........QTY : 01 KGS NET ....ORIGIN & SHIPMENT FROM : CHINA .......BRAND : DALIAN
Expand
Product description
EXPERIMENTAL SAMPLE FOR TECHNICAL TRIAL FOR LABORATORY USE ONLY...........DACLATASVIR DIHYDROCHLORIDE ...QTY ; .75.2 g NET......ORIGIN : CHINA.....
Expand
Trade date
2025/03/19
B/L No.
0307602
Suppliers
suli pharmaceutical technologies jian
Buyers
sun pharmaceutical industries lilmited
suli pharmaceutical technologies jian is china Supplier,
and primarily engages in the import and export business of products such as pyrrolo,cas no,ethyl.
According to the 52wmb.com global trade database, as of 2026-04-30, the company has completed 25 international trades,
with its main trading regions covering india,pakistan etc.
The core products include HS29339990,HS29333990,HS29420090 etc,
and its main trading partners are sun pharmaceutical industries ltd.,cipla ltd.,teva api india ltd.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on suli pharmaceutical technologies jian is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.